Shaping the Future of Life Sciences.
KYBORA’s Founder and CEO, Alan Vanderborght, participated in BioArbor Life Science Forum in a special Fireside Chat in Ann Arbor, Michigan, an event where leading figures and innovators from the life sciences sector are brought together to discuss emerging challenges and opportunities.
With more than 25 years guiding global biopharma strategies, Alan shared his perspective about the realities of the market: tough fundraising conditions, licensing and deal-making, global market shifts, and the evolving role of technology across the value chain.
The conversation addressed challenges directly, discussing value creation and destruction, as well as the actions leaders may need to take in response to capital constraints, regulatory requirements, and evolving investor expectations.
The event showcased the dynamism of the region’s biotech, pharma, medtech, and health tech community, reinforcing BioArbor’s role as a platform for dialogue, innovation and growth within the life sciences ecosystem.
Alan’s participation highlights KYBORA’s commitment to guiding transformative healthcare companies to enduring success globally.
20 years of experience in international business development in the pharmaceutical industry. Head of commercial operations and business development for Bristol-Myers Squibb in 16 Latin American countries. Global management consultant. Speaks French and Spanish fluently. Completed nine transactions in global markets in the past three years.